betamethasone has been researched along with Cerebral Malaria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Allon, N; Avichzer, J; Barenholz, Y; Bentura-Marciano, A; Even-Chen, S; Golenser, J; Haynes, RK; Ovadia, H; Turjeman, K; Waknine-Grinberg, JH; Weiss, L | 1 |
| Barenholz, Y; Golenser, J; Guo, J; Mitchell, AJ; Waknine-Grinberg, JH | 1 |
2 other study(ies) available for betamethasone and Cerebral Malaria
| Article | Year |
|---|---|
Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria.
Topics: Acute Disease; Animals; Base Sequence; Betamethasone; Disease Models, Animal; DNA Primers; Liposomes; Malaria, Cerebral; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Nanoparticles; Plasmodium berghei; Real-Time Polymerase Chain Reaction | 2013 |
Reduction of experimental cerebral malaria and its related proinflammatory responses by the novel liposome-based β-methasone nanodrug.
Topics: Animals; Betamethasone; Blood-Brain Barrier; Chemokines; Disease Models, Animal; Drug Delivery Systems; Humans; Inflammation; Liposomes; Malaria, Cerebral; Mice; Nanoparticles; Plasmodium berghei; Plasmodium falciparum; Th1-Th2 Balance | 2014 |